1. DIPG-27. OPTIMIZING CLINICAL TRIAL DESIGN: PHARMACOKINETICS OF MARIZOMIB AND PANOBINOSTAT IN A NON-HUMAN PRIMATE MODEL. (23rd April 2019) Authors: Warren, Katherine; Shankarappa, Priya; Peer, Cody; Garcia, Rafael Cruz; Monje-Deisseroth, Michelle; Figg, W Doug; McCully, Cynthia Lester Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 2 Page Start: ii74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXTH-25. THE CSF PENETRATION OF THE PROCASPASE-ACTIVATING COMPOUND (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN A NONHUMAN PRIMATE CSF ACCESS MODEL. (9th November 2020) Authors: Lester McCully, Cynthia; Shankarappa, Priya; Garcia, Rafael Cruz; Peer, Cody; Zakharov, Alexander; Fischer, James; Lyubimov, Alexander; Hergenrother, Paul; Thomas, Marvin; Figg, William; Warren, Katherine Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EXTH-65. PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS COMPARISON OF BRAF AND MEK INHIBITORS FOLLOWING SINGLE AND EXTENDED ADMINISTRATION IN A PRE-CLINICAL NON-HUMAN PRIMATE MODEL. (11th November 2019) Authors: Lester McCully, Cynthia; Gross, Andrea; Cruz Garcia, Rafael; Shankarappa, Priya; Odabas, Arman; Rodgers, Louis; Peer, Cody; Figg, William; Widemann, Brigitte; Warren, Katherine Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗